Search research articles
Contact Us
Filters
Showing results (131-140 of 153) with videos related to
Page
of 16
Sort By:
Blood
|
March 4, 2015
β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome
Kenji Tanimura, Hui Jin, Tadahiro Suenaga, et al.
Rheumatology International
|
May 24, 2014
The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database
Ryoko Sakai, Soo-Kyung Cho, Toshihiro Nanki, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2005
Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle
J Pablo Abonia, Daniel S Friend, William G Austen, et al.
Annals of the Rheumatic Diseases
|
July 4, 2015
The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression
Tatsuya Atsumi, Kazuhiko Yamamoto, Tsutomu Takeuchi, et al.
Annals of the Rheumatic Diseases
|
February 4, 2017
Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial
Tatsuya Atsumi, Yoshiya Tanaka, Kazuhiko Yamamoto, et al.
Modern Rheumatology
|
December 16, 2014
Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia
Michi Tanaka, Ryuji Koike, Ryoko Sakai, et al.
Modern Rheumatology
|
December 7, 2016
Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategy
Fumio Hirano, Waka Yokoyama, Hayato Yamazaki, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 22, 2023
Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19
Tadashi Hosoya, Seiya Oba, Yoji Komiya, et al.
Modern Rheumatology
|
February 3, 2017
Maintenance treatment using abatacept with dose reduction after achievement of low disease activity in patients with rheumatoid arthritis (MATADOR) - A prospective, multicenter, single arm pilot clinical trial
Shinsuke Yasuda, Kazumasa Ohmura, Hiroshi Kanazawa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 20, 2024
Muscle Tissue Transcriptome of Idiopathic Inflammatory Myopathy Reflects the Muscle Damage Process by Monocytes and Presence of Skin Lesions
Shinji Izuka, Natsuka Umezawa, Toshihiko Komai, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 153) with videos related to
Sort By:
Page
of 16
Blood
|
March 4, 2015
β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome
Kenji Tanimura, Hui Jin, Tadahiro Suenaga, et al.
Rheumatology International
|
May 24, 2014
The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database
Ryoko Sakai, Soo-Kyung Cho, Toshihiro Nanki, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2005
Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle
J Pablo Abonia, Daniel S Friend, William G Austen, et al.
Annals of the Rheumatic Diseases
|
July 4, 2015
The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression
Tatsuya Atsumi, Kazuhiko Yamamoto, Tsutomu Takeuchi, et al.
Annals of the Rheumatic Diseases
|
February 4, 2017
Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial
Tatsuya Atsumi, Yoshiya Tanaka, Kazuhiko Yamamoto, et al.
Modern Rheumatology
|
December 16, 2014
Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia
Michi Tanaka, Ryuji Koike, Ryoko Sakai, et al.
Modern Rheumatology
|
December 7, 2016
Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategy
Fumio Hirano, Waka Yokoyama, Hayato Yamazaki, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 22, 2023
Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19
Tadashi Hosoya, Seiya Oba, Yoji Komiya, et al.
Modern Rheumatology
|
February 3, 2017
Maintenance treatment using abatacept with dose reduction after achievement of low disease activity in patients with rheumatoid arthritis (MATADOR) - A prospective, multicenter, single arm pilot clinical trial
Shinsuke Yasuda, Kazumasa Ohmura, Hiroshi Kanazawa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 20, 2024
Muscle Tissue Transcriptome of Idiopathic Inflammatory Myopathy Reflects the Muscle Damage Process by Monocytes and Presence of Skin Lesions
Shinji Izuka, Natsuka Umezawa, Toshihiko Komai, et al.
Page
of 16